INCY vs XXII · P/E 14, rev $5.14B vs rev $7.0M
Incyte Corporation (INCY) versus 22nd Century Group Inc (XXII) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
22nd Century Group Inc (XXII) is a tobacco company listed on NASDAQ.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported XXII revenue for 2026-06-30 was $7.0M. Net income was -$6.6M. Revenue was up 69.8% from 2026-03-31 to 2026-06-30. XXII currently screens at market cap $1.9M.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. XXII currently screens at market cap $1.9M.
Not investment advice. Open the INCY and XXII stock pages for the full models.
Not investment advice.